14-day Premium Trial Subscription Try For FreeTry Free
$39.35
+1.93 (+5.16%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $35.67 $41.84 Wednesday, 1st May 2024 CLDX stock ended at $39.35. This is 5.16% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.94% from a day low at $37.49 to a day high of $40.84.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Dec 09, 2021 $39.73 $39.74 $37.09 $37.23 302 428
Dec 08, 2021 $39.08 $40.30 $38.00 $39.73 283 574
Dec 07, 2021 $36.81 $39.22 $36.81 $38.77 399 393
Dec 06, 2021 $35.90 $36.89 $35.00 $36.42 471 318
Dec 03, 2021 $37.66 $37.97 $35.00 $35.68 422 867
Dec 02, 2021 $36.34 $37.96 $35.48 $37.61 305 103
Dec 01, 2021 $38.66 $39.81 $36.05 $36.09 382 394
Nov 30, 2021 $38.41 $39.33 $36.79 $38.10 872 726
Nov 29, 2021 $39.70 $40.82 $38.60 $38.72 416 600
Nov 26, 2021 $40.51 $41.37 $38.03 $39.61 434 428
Nov 24, 2021 $40.64 $41.22 $39.73 $41.12 455 001
Nov 23, 2021 $41.66 $42.42 $39.62 $40.87 503 315
Nov 22, 2021 $43.18 $43.32 $41.27 $41.54 378 523
Nov 19, 2021 $42.57 $43.79 $41.96 $42.98 472 567
Nov 18, 2021 $43.61 $45.25 $42.21 $42.52 382 024
Nov 17, 2021 $44.37 $45.28 $43.38 $43.82 234 741
Nov 16, 2021 $42.76 $44.93 $42.50 $44.87 248 624
Nov 15, 2021 $42.11 $44.40 $42.11 $43.01 376 513
Nov 12, 2021 $44.38 $44.38 $41.35 $41.97 421 820
Nov 11, 2021 $45.86 $46.38 $44.34 $44.40 204 247
Nov 10, 2021 $45.26 $46.69 $44.77 $45.71 262 492
Nov 09, 2021 $45.57 $46.31 $44.33 $45.91 153 284
Nov 08, 2021 $46.40 $46.77 $45.37 $45.44 225 592
Nov 05, 2021 $46.80 $46.80 $44.56 $45.87 312 388
Nov 04, 2021 $48.38 $48.38 $45.50 $46.53 494 515
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT